Angelman Syndrome Natural History Study
Launched by BOSTON CHILDREN'S HOSPITAL · Aug 8, 2020
Trial Information
Current as of May 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Angelman Syndrome Natural History Study is a research project aimed at understanding how Angelman Syndrome affects children and adults over time. The study will gather information directly from medical professionals and parents to help create a better picture of this condition, which can support future clinical trials looking for new treatments.
To participate, individuals must have a confirmed diagnosis of Angelman Syndrome and should not have any other unrelated conditions that affect brain development. The study is currently looking for participants of all ages and genders. Those who join can expect to share their experiences and health information, which will contribute to important research that could lead to better care for people with Angelman Syndrome in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Molecular diagnosis of Angelman syndrome
- Exclusion Criteria:
- • Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Ottawa, Ontario, Canada
Aurora, Colorado, United States
Boston, Massachusetts, United States
San Diego, California, United States
Calgary, Alberta, Canada
Nashville, Tennessee, United States
Vancouver, British Columbia, Canada
Chicago, Illinois, United States
Atlanta, Georgia, United States
Carrboro, North Carolina, United States
Los Angeles, California, United States
Aurora, Colorado, United States
Patients applied
Trial Officials
Wen-Hann Tan, BMBS
Study Chair
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials